Pre-order Enquiry
Request Free Sample
Global Pharma 4.0 Market Research Report 2022
SKU ID : QYR-21132668 | Publishing Date : 23-Jun-2022 | No. of pages : 98
Detailed TOC of Global Pharma 4.0 Market Research Report 2022
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharma 4.0 Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Cloud
1.2.3 On-premise
1.3 Market by Application
1.3.1 Global Pharma 4.0 Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical Industry
1.3.3 IoT Industry
1.3.4 Medical Equipment Industry
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Pharma 4.0 Market Perspective (2017-2028)
2.2 Pharma 4.0 Growth Trends by Region
2.2.1 Pharma 4.0 Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Pharma 4.0 Historic Market Size by Region (2017-2022)
2.2.3 Pharma 4.0 Forecasted Market Size by Region (2023-2028)
2.3 Pharma 4.0 Market Dynamics
2.3.1 Pharma 4.0 Industry Trends
2.3.2 Pharma 4.0 Market Drivers
2.3.3 Pharma 4.0 Market Challenges
2.3.4 Pharma 4.0 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharma 4.0 Players by Revenue
3.1.1 Global Top Pharma 4.0 Players by Revenue (2017-2022)
3.1.2 Global Pharma 4.0 Revenue Market Share by Players (2017-2022)
3.2 Global Pharma 4.0 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharma 4.0 Revenue
3.4 Global Pharma 4.0 Market Concentration Ratio
3.4.1 Global Pharma 4.0 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharma 4.0 Revenue in 2021
3.5 Pharma 4.0 Key Players Head office and Area Served
3.6 Key Players Pharma 4.0 Product Solution and Service
3.7 Date of Enter into Pharma 4.0 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharma 4.0 Breakdown Data by Type
4.1 Global Pharma 4.0 Historic Market Size by Type (2017-2022)
4.2 Global Pharma 4.0 Forecasted Market Size by Type (2023-2028)
5 Pharma 4.0 Breakdown Data by Application
5.1 Global Pharma 4.0 Historic Market Size by Application (2017-2022)
5.2 Global Pharma 4.0 Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Pharma 4.0 Market Size (2017-2028)
6.2 North America Pharma 4.0 Market Size by Country (2017-2022)
6.3 North America Pharma 4.0 Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Pharma 4.0 Market Size (2017-2028)
7.2 Europe Pharma 4.0 Market Size by Country (2017-2022)
7.3 Europe Pharma 4.0 Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharma 4.0 Market Size (2017-2028)
8.2 Asia-Pacific Pharma 4.0 Market Size by Country (2017-2022)
8.3 Asia-Pacific Pharma 4.0 Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Pharma 4.0 Market Size (2017-2028)
9.2 Latin America Pharma 4.0 Market Size by Country (2017-2022)
9.3 Latin America Pharma 4.0 Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharma 4.0 Market Size (2017-2028)
10.2 Middle East & Africa Pharma 4.0 Market Size by Country (2017-2022)
10.3 Middle East & Africa Pharma 4.0 Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Pfizer Inc
11.1.1 Pfizer Inc Company Detail
11.1.2 Pfizer Inc Business Overview
11.1.3 Pfizer Inc Pharma 4.0 Introduction
11.1.4 Pfizer Inc Revenue in Pharma 4.0 Business (2017-2022)
11.1.5 Pfizer Inc Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Pharma 4.0 Introduction
11.2.4 Abbott Laboratories Revenue in Pharma 4.0 Business (2017-2022)
11.2.5 Abbott Laboratories Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Detail
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Pharma 4.0 Introduction
11.3.4 GE Healthcare Revenue in Pharma 4.0 Business (2017-2022)
11.3.5 GE Healthcare Recent Development
11.4 Boston Scientific
11.4.1 Boston Scientific Company Detail
11.4.2 Boston Scientific Business Overview
11.4.3 Boston Scientific Pharma 4.0 Introduction
11.4.4 Boston Scientific Revenue in Pharma 4.0 Business (2017-2022)
11.4.5 Boston Scientific Recent Development
11.5 Medtronic Plc.
11.5.1 Medtronic Plc. Company Detail
11.5.2 Medtronic Plc. Business Overview
11.5.3 Medtronic Plc. Pharma 4.0 Introduction
11.5.4 Medtronic Plc. Revenue in Pharma 4.0 Business (2017-2022)
11.5.5 Medtronic Plc. Recent Development
11.6 Lonza Group AG
11.6.1 Lonza Group AG Company Detail
11.6.2 Lonza Group AG Business Overview
11.6.3 Lonza Group AG Pharma 4.0 Introduction
11.6.4 Lonza Group AG Revenue in Pharma 4.0 Business (2017-2022)
11.6.5 Lonza Group AG Recent Development
11.7 GlaxoSmithKline plc.
11.7.1 GlaxoSmithKline plc. Company Detail
11.7.2 GlaxoSmithKline plc. Business Overview
11.7.3 GlaxoSmithKline plc. Pharma 4.0 Introduction
11.7.4 GlaxoSmithKline plc. Revenue in Pharma 4.0 Business (2017-2022)
11.7.5 GlaxoSmithKline plc. Recent Development
11.8 Koninklijke Philips N.V.
11.8.1 Koninklijke Philips N.V. Company Detail
11.8.2 Koninklijke Philips N.V. Business Overview
11.8.3 Koninklijke Philips N.V. Pharma 4.0 Introduction
11.8.4 Koninklijke Philips N.V. Revenue in Pharma 4.0 Business (2017-2022)
11.8.5 Koninklijke Philips N.V. Recent Development
11.9 Glatt GmbH
11.9.1 Glatt GmbH Company Detail
11.9.2 Glatt GmbH Business Overview
11.9.3 Glatt GmbH Pharma 4.0 Introduction
11.9.4 Glatt GmbH Revenue in Pharma 4.0 Business (2017-2022)
11.9.5 Glatt GmbH Recent Development
11.10 Vertex
11.10.1 Vertex Company Detail
11.10.2 Vertex Business Overview
11.10.3 Vertex Pharma 4.0 Introduction
11.10.4 Vertex Revenue in Pharma 4.0 Business (2017-2022)
11.10.5 Vertex Recent Development
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Detail
11.11.2 Johnson & Johnson Business Overview
11.11.3 Johnson & Johnson Pharma 4.0 Introduction
11.11.4 Johnson & Johnson Revenue in Pharma 4.0 Business (2017-2022)
11.11.5 Johnson & Johnson Recent Development
11.12 Goodly Innovations
11.12.1 Goodly Innovations Company Detail
11.12.2 Goodly Innovations Business Overview
11.12.3 Goodly Innovations Pharma 4.0 Introduction
11.12.4 Goodly Innovations Revenue in Pharma 4.0 Business (2017-2022)
11.12.5 Goodly Innovations Recent Development
11.13 QbDVision
11.13.1 QbDVision Company Detail
11.13.2 QbDVision Business Overview
11.13.3 QbDVision Pharma 4.0 Introduction
11.13.4 QbDVision Revenue in Pharma 4.0 Business (2017-2022)
11.13.5 QbDVision Recent Development
11.14 Electrosan
11.14.1 Electrosan Company Detail
11.14.2 Electrosan Business Overview
11.14.3 Electrosan Pharma 4.0 Introduction
11.14.4 Electrosan Revenue in Pharma 4.0 Business (2017-2022)
11.14.5 Electrosan Recent Development
11.15 GoSilico
11.15.1 GoSilico Company Detail
11.15.2 GoSilico Business Overview
11.15.3 GoSilico Pharma 4.0 Introduction
11.15.4 GoSilico Revenue in Pharma 4.0 Business (2017-2022)
11.15.5 GoSilico Recent Development
11.16 Smart Factory
11.16.1 Smart Factory Company Detail
11.16.2 Smart Factory Business Overview
11.16.3 Smart Factory Pharma 4.0 Introduction
11.16.4 Smart Factory Revenue in Pharma 4.0 Business (2017-2022)
11.16.5 Smart Factory Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Pharma 4.0 Market Research Report 2022
List of TablesTable 1. Global Pharma 4.0 Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Cloud
Table 3. Key Players of On-premise
Table 4. Global Pharma 4.0 Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Pharma 4.0 Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Pharma 4.0 Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Pharma 4.0 Market Share by Region (2017-2022)
Table 8. Global Pharma 4.0 Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Pharma 4.0 Market Share by Region (2023-2028)
Table 10. Pharma 4.0 Market Trends
Table 11. Pharma 4.0 Market Drivers
Table 12. Pharma 4.0 Market Challenges
Table 13. Pharma 4.0 Market Restraints
Table 14. Global Pharma 4.0 Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Pharma 4.0 Market Share by Players (2017-2022)
Table 16. Global Top Pharma 4.0 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma 4.0 as of 2021)
Table 17. Ranking of Global Top Pharma 4.0 Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Pharma 4.0 Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pharma 4.0 Product Solution and Service
Table 21. Date of Enter into Pharma 4.0 Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pharma 4.0 Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Pharma 4.0 Revenue Market Share by Type (2017-2022)
Table 25. Global Pharma 4.0 Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Pharma 4.0 Revenue Market Share by Type (2023-2028)
Table 27. Global Pharma 4.0 Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Pharma 4.0 Revenue Market Share by Application (2017-2022)
Table 29. Global Pharma 4.0 Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Pharma 4.0 Revenue Market Share by Application (2023-2028)
Table 31. North America Pharma 4.0 Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America Pharma 4.0 Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe Pharma 4.0 Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe Pharma 4.0 Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific Pharma 4.0 Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific Pharma 4.0 Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America Pharma 4.0 Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America Pharma 4.0 Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa Pharma 4.0 Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa Pharma 4.0 Market Size by Country (2023-2028) & (US$ Million)
Table 41. Pfizer Inc Company Detail
Table 42. Pfizer Inc Business Overview
Table 43. Pfizer Inc Pharma 4.0 Product
Table 44. Pfizer Inc Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
Table 45. Pfizer Inc Recent Development
Table 46. Abbott Laboratories Company Detail
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Pharma 4.0 Product
Table 49. Abbott Laboratories Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. GE Healthcare Company Detail
Table 52. GE Healthcare Business Overview
Table 53. GE Healthcare Pharma 4.0 Product
Table 54. GE Healthcare Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
Table 55. GE Healthcare Recent Development
Table 56. Boston Scientific Company Detail
Table 57. Boston Scientific Business Overview
Table 58. Boston Scientific Pharma 4.0 Product
Table 59. Boston Scientific Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
Table 60. Boston Scientific Recent Development
Table 61. Medtronic Plc. Company Detail
Table 62. Medtronic Plc. Business Overview
Table 63. Medtronic Plc. Pharma 4.0 Product
Table 64. Medtronic Plc. Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
Table 65. Medtronic Plc. Recent Development
Table 66. Lonza Group AG Company Detail
Table 67. Lonza Group AG Business Overview
Table 68. Lonza Group AG Pharma 4.0 Product
Table 69. Lonza Group AG Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
Table 70. Lonza Group AG Recent Development
Table 71. GlaxoSmithKline plc. Company Detail
Table 72. GlaxoSmithKline plc. Business Overview
Table 73. GlaxoSmithKline plc. Pharma 4.0 Product
Table 74. GlaxoSmithKline plc. Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
Table 75. GlaxoSmithKline plc. Recent Development
Table 76. Koninklijke Philips N.V. Company Detail
Table 77. Koninklijke Philips N.V. Business Overview
Table 78. Koninklijke Philips N.V. Pharma 4.0 Product
Table 79. Koninklijke Philips N.V. Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
Table 80. Koninklijke Philips N.V. Recent Development
Table 81. Glatt GmbH Company Detail
Table 82. Glatt GmbH Business Overview
Table 83. Glatt GmbH Pharma 4.0 Product
Table 84. Glatt GmbH Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
Table 85. Glatt GmbH Recent Development
Table 86. Vertex Company Detail
Table 87. Vertex Business Overview
Table 88. Vertex Pharma 4.0 Product
Table 89. Vertex Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
Table 90. Vertex Recent Development
Table 91. Johnson & Johnson Company Detail
Table 92. Johnson & Johnson Business Overview
Table 93. Johnson & Johnson Pharma 4.0Product
Table 94. Johnson & Johnson Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
Table 95. Johnson & Johnson Recent Development
Table 96. Goodly Innovations Company Detail
Table 97. Goodly Innovations Business Overview
Table 98. Goodly Innovations Pharma 4.0Product
Table 99. Goodly Innovations Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
Table 100. Goodly Innovations Recent Development
Table 101. QbDVision Company Detail
Table 102. QbDVision Business Overview
Table 103. QbDVision Pharma 4.0Product
Table 104. QbDVision Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
Table 105. QbDVision Recent Development
Table 106. Electrosan Company Detail
Table 107. Electrosan Business Overview
Table 108. Electrosan Pharma 4.0Product
Table 109. Electrosan Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
Table 110. Electrosan Recent Development
Table 111. GoSilico Company Detail
Table 112. GoSilico Business Overview
Table 113. GoSilico Pharma 4.0Product
Table 114. GoSilico Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
Table 115. GoSilico Recent Development
Table 116. Smart Factory Company Detail
Table 117. Smart Factory Business Overview
Table 118. Smart Factory Pharma 4.0Product
Table 119. Smart Factory Revenue in Pharma 4.0 Business (2017-2022) & (US$ Million)
Table 120. Smart Factory Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharma 4.0 Market Share by Type: 2021 VS 2028
Figure 2. Cloud Features
Figure 3. On-premise Features
Figure 4. Global Pharma 4.0 Market Share by Application in 2021 & 2028
Figure 5. Pharmaceutical Industry Case Studies
Figure 6. IoT Industry Case Studies
Figure 7. Medical Equipment Industry Case Studies
Figure 8. Others Case Studies
Figure 9. Pharma 4.0 Report Years Considered
Figure 10. Global Pharma 4.0 Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Pharma 4.0 Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Pharma 4.0 Market Share by Region: 2021 VS 2028
Figure 13. Global Pharma 4.0 Market Share by Players in 2021
Figure 14. Global Top Pharma 4.0 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma 4.0 as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Pharma 4.0 Revenue in 2021
Figure 16. North America Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Pharma 4.0 Market Share by Country (2017-2028)
Figure 18. United States Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Pharma 4.0 Market Share by Country (2017-2028)
Figure 22. Germany Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Pharma 4.0 Market Share by Region (2017-2028)
Figure 30. China Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Pharma 4.0 Market Share by Country (2017-2028)
Figure 38. Mexico Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Pharma 4.0 Market Share by Country (2017-2028)
Figure 42. Turkey Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Pharma 4.0 Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Pfizer Inc Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
Figure 45. Abbott Laboratories Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
Figure 46. GE Healthcare Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
Figure 47. Boston Scientific Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
Figure 48. Medtronic Plc. Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
Figure 49. Lonza Group AG Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
Figure 50. GlaxoSmithKline plc. Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
Figure 51. Koninklijke Philips N.V. Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
Figure 52. Glatt GmbH Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
Figure 53. Vertex Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
Figure 54. Johnson & Johnson Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
Figure 55. Goodly Innovations Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
Figure 56. QbDVision Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
Figure 57. Electrosan Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
Figure 58. GoSilico Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
Figure 59. Smart Factory Revenue Growth Rate in Pharma 4.0 Business (2017-2022)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Keyplayers in Global Pharma 4.0 Market Research Report 2022
Pfizer IncAbbott Laboratories
GE Healthcare
Boston Scientific
Medtronic Plc.
Lonza Group AG
GlaxoSmithKline plc.
Koninklijke Philips N.V.
Glatt GmbH
Vertex
Johnson & Johnson
Goodly Innovations
QbDVision
Electrosan
GoSilico
Smart Factory
Request Sample
Request Discount
